跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 855 条关于
“Ankylosing Spondylitis”
全部
855
临床试验
757
药物
11
机构
0
资讯
87
2年前
Tofacitinib Demonstrates Efficacy in Ankylosing Spondylitis Regardless of CRP Levels
去年
Ankylosing Spondylitis Pipeline Shows Robust Growth with 20+ Therapies in Development
去年
Vunakizumab Shows Promise in Treating Active Ankylosing Spondylitis in Phase 2/3 Study
去年
Tofacitinib Shows Promising Results in Phase III Trial for Ankylosing Spondylitis Treatment
3个月前
Livzon's IL-17 Inhibitor Lecankitug Nears Second Indication as NMPA Accepts Ankylosing Spondylitis Application
去年
Real-World Study Shows Adalimumab Biosimilar IBI303 Matches Humira Efficacy with Superior Cost Benefits in Ankylosing Spondylitis
去年
Spinal Cord Injury and Ankylosing Spondylitis: Advances in Clinical Trials and Therapies
5年前
UCB Announces U.S. FDA Approvals for BIMZELX® (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
去年
FDA Accepts Alvotech and Teva's Biosimilar Application for Golimumab (AVT05)
10个月前
European Commission Approves World's First Liquid Formulation of IV Infliximab, Promising Significant Cost Savings
第 1 页,共 9 页
上一页
下一页